Management of Placenta Accreta Spectrum

Overview

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Other
    • Masking: None (Open Label)
  • Study Primary Completion Date: December 31, 2021

Detailed Description

placenta accreta spectrum is group of disorders which have a depate about the best way of management. this is a descriptive study about the best techniques to reduce morbidity and mortalities related to it. 1. surgical management of placenta accreta 2. short term follow up to the outcomes 3. long term follow up

Interventions

  • Procedure: Management of placenta accreta spectrum
    • Conservative and radical (hysterectomy) treatment of placenta accreta. Follow up to the patients to detect the impact of treatment imposed A novel technique which early identification and repait of uterine wall defects resulted from invasion of the uterine wall by the placenta.

Clinical Trial Outcome Measures

Primary Measures

  • Failure of the novel conservative management
    • Time Frame: 3 hours
    • Need to do peripartum hysterectomy or patient death
  • Estimated amount of blood loss
    • Time Frame: 6 hours
    • The estimated amount of blood loss during and after surgery

Participating in This Clinical Trial

Inclusion Criteria

  • All placenta accreta e high possibility of placenta accrete – consent – easy follow up visits Exclusion Criteria:

  • bleeding tendency – associated medical disorder hypertension, diabetes, preeclapsia..

Gender Eligibility: Female

Minimum Age: 18 Years

Maximum Age: 40 Years

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Assiut University
  • Provider of Information About this Clinical Study
    • Principal Investigator: Osama Saber Thabet Abdalmageed, Principal Investigator – Assiut University
  • Overall Contact(s)
    • Osama Abdalmageed, 01012234876, drosamast@aun.edu.eg

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.